05/01/2018 04:55 PM EDT
Biomedical engineers at Duke University have used a CRISPR/Cas9 genetic engineering technique to turn off a gene that regulates cholesterol levels in adult mice, leading to reduced blood cholesterol levels and gene repression lasting for six months after a single treatment. This marks the first time researchers have delivered CRISPR/Cas9 repressors for targeted therapeutic gene silencing in adult animal models. Source Duke University
|
Tuesday, May 1, 2018
CRISPR/Cas9 silences gene associated with high cholesterol
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment